High-Risk Mobility and Interruption in HIV Treatment Among Men in Malawi: Secondary Analysis of Two Randomized Controlled Trials

Abstract Mobility is a key risk factor for interruption in HIV treatment (IIT). However, little is known about which aspects of mobility confer greatest risk (i.e., comprise high-risk mobility) and whether people prone to high-risk mobility can be identified prior to events. We conducted a secondary analysis of the IDEaL and ENGAGE trials (ClinicalTrials.gov #NCT04858243; #NCT05137210), which tested interventions to improve 6-month ART engagement among men living with HIV (MLHIV; ≥ 15 years old) not in care (i.e., ART naïve or missed refill by ≥ 28 days) in Malawi. We used baseline and endline (4–7 months post-enrollment) surveys and medical chart reviews of established ART clients experiencing IIT at enrollment who re-initiated ART during trials. We used Poisson regressions with random effects and receiver operator characteristic (ROC) curves to identify mobility characteristics most strongly associated with repeat IIT ( ≥ 28 days late for ART appointment during 6-month trial period) and to identify associated baseline characteristics. Of 1,119 men, 454 (41%) experienced repeat IIT; 314 (28%) took ≥ 3-night trips during the 6-month trial period. Trips ≥ 30 nights (aIRR 1.51, 95%CI 1.14–1.99, AUC 0.648) and lasting longer than expected (aIRR 1.50, 95%CI 1.15–1.96, AUC 0.653) best predicted repeat IIT (specificity 90%). No sociodemographic or pre-trial mobility variables were independently associated with high-risk mobility during the trial period. Mobility is a key risk factor for IIT among men in Malawi, and we found “high-risk mobility” to be trips ≥ 30 nights and/or that lasted longer than expected. We were unable to predict which men would experience high-risk mobility.

Authors

Institutions

Publication Details

Journal
AIDS and Behavior
Published
2026-11-15
DOI
https://doi.org/10.1007/s10461-026-05328-7
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

High-Risk Mobility and Interruption in HIV Treatment Among Men in Malawi: Secondary Analysis of Two Randomized Controlled Trials

Joep J. van Oosterhout, Risa M. Hoffman, Augustine Talumba Choko, Marguerite Thorp et al.
AIDS and Behavior
HIV/AIDS Research and Interventions
article

High-Risk Mobility and Interruption in HIV Treatment Among Men in Malawi: Secondary Analysis of Two Randomized Controlled Trials

Joep J. van Oosterhout, Risa M. Hoffman, Augustine Talumba Choko, Marguerite Thorp, Kelvin T. Balakasi, Morna Cornell, Isabella Robson, Kathryn L. Dovel, Steve Shoptaw, Mira Ramesh
article en

Abstract

Abstract Mobility is a key risk factor for interruption in HIV treatment (IIT). However, little is known about which aspects of mobility confer greatest risk (i.e., comprise high-risk mobility) and whether people prone to high-risk mobility can be identified prior to events. We conducted a secondary analysis of the IDEaL and ENGAGE trials (ClinicalTrials.gov #NCT04858243; #NCT05137210), which tested interventions to improve 6-month ART engagement among men living with HIV (MLHIV; ≥ 15 years old) not in care (i.e., ART naïve or missed refill by ≥ 28 days) in Malawi. We used baseline and endline (4–7 months post-enrollment) surveys and medical chart reviews of established ART clients experiencing IIT at enrollment who re-initiated ART during trials. We used Poisson regressions with random effects and receiver operator characteristic (ROC) curves to identify mobility characteristics most strongly associated with repeat IIT ( ≥ 28 days late for ART appointment during 6-month trial period) and to identify associated baseline characteristics. Of 1,119 men, 454 (41%) experienced repeat IIT; 314 (28%) took ≥ 3-night trips during the 6-month trial period. Trips ≥ 30 nights (aIRR 1.51, 95%CI 1.14–1.99, AUC 0.648) and lasting longer than expected (aIRR 1.50, 95%CI 1.15–1.96, AUC 0.653) best predicted repeat IIT (specificity 90%). No sociodemographic or pre-trial mobility variables were independently associated with high-risk mobility during the trial period. Mobility is a key risk factor for IIT among men in Malawi, and we found “high-risk mobility” to be trips ≥ 30 nights and/or that lasted longer than expected. We were unable to predict which men would experience high-risk mobility.

AIDS and Behavior
University of Cape Town (ZA), University of California, Los Angeles (US), University of Pittsburgh (US), Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MW)
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon